MEDNAX (MD) Misses Q3 EPS by 14c
Tweet
Share
E-mail
Get Alerts MD Hot Sheet
Join SI Premium – FREE
MEDNAX (NYSE: MD) reported Q3 EPS of $0.23, $0.14 worse than the analyst estimate of $0.37. Revenue for the quarter came in at $511 million versus the consensus estimate of $498.87 million.
For earnings history and earnings-related data on MEDNAX (MD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Agora Inc. (API) PT Raised to $6.80 at BofA Securities
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
